Demystifying Medicine Video

Kawasaki disease (KD) is an illness that causes inflammation in the blood vessels throughout the body. It was first identified in Japan by Tomisaku Kawasaki in 1967 and is now the most common cause of childhood-acquired heart disease in Western countries. Despite this, the cause of KD is yet to be determined. In addition, despite its wide prevalence, the symptoms of the disease are often misunderstood. This video provides a holistic understanding of Kawasaki Disease including signs, symptoms, treatments, coping strategies and more. We hope that this video is useful for parents with children who are diagnosed with Kawasaki Disease, as it was made with the goal of aiding in the decision-making process regarding their child's health.

[Please complete our feedback form]

  • Burns, J. C., & Glodé, M. P. (2004). Kawasaki syndrome. The Lancet, 364(9433), 533-544.
  • Cronan, K.M. (2019). Kawasaki Disease. KidsHealth from Nemours.
  • Fukazawa, R. (2010). Long-term prognosis of Kawasaki disease: increased cardiovascular risk? Current opinion in pediatrics, 22(5), 587-592.
  • Kawasaki Disease (Mucocutaneous Lymph Node Syndrome). (2004). HealthEngine.
  • Kim, D.S. (2006). Kawasaki Disease. Yonsei Medical Journal, 47(6): 759-772). doi:10.3349/ymj.2006.47.6.759
  • Kim, G.B. (2019). Reality of Kawasaki Disease Epidemiology. Korean Journal of Pediatrics, 62(8): 292-296. doi:10.3345/kjp.2019.00157
  • Lang, B. (2001). Recognizing Kawasaki disease. Paediatrics & child health, 6(9), 638-643.
  • McCrindle, B. W., Rowley, A. H., Newburger, J. W., Burns, J. C., Bolger, A. F., Gewitz, M., ... & Kobayashi, T. (2017). Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation, 135(17), e927-e999.
  • Newburger, J.W. & Burns, J.C. (1999). Kawasaki Disease. Vascular Medicine, 4: 187-202. doi:10.1191/135886399673367277
  • Newburger, J. W., Takahashi, M., & Burns, J. C. (2016). Kawasaki disease. Journal of the American College of Cardiology, 67(14), 1738-1749.
  • Newburger, J. W., Takahashi, M., Gerber, M. A., Gewitz, M. H., Tani, L. Y., Burns, J. C., ... & Wilson, W. R. (2004). Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 110(17), 2747-2771.
  • Onouchi, Y. (2009). Molecular Genetics of Kawasaki Disease. Pediatric Research, 65: 56-54. doi:10.1203/PDR.0b013e31819dba60
  • Raab, C.P. (2019). Kawasaki Disease. Merck Manual Professional Version.
  • Ramphul, K., & Mejias, S. G. (2018). Kawasaki disease: a comprehensive review. Archives of medical sciences. Atherosclerotic diseases, 3, e41.
  • Shulman, S. T., & Rowley, A. H. (2015). Kawasaki disease: insights into pathogenesis and approaches to treatment. Nature Reviews Rheumatology, 11(8), 475.

Accessibility for Ontarians With Disabilities Act (AODA)


The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at